Selective COX-2 inhibitors for short-term musculoskeletal pain in inflammatory bowel disease in remission: a narrative review - Top-Institutions - MDSpire

Selective COX-2 inhibitors for short-term musculoskeletal pain in inflammatory bowel disease in remission: a narrative review

  • By

  • Michiel A van Nieuwenhoven

  • July 13, 2026

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    The Johns Hopkins Hospital
    The Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Rheumatology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Rheumatology

Original Source(s)

Selective COX-2 inhibitors for short-term musculoskeletal pain in inflammatory bowel disease in remission: a narrative review

  • by Michiel A van Nieuwenhoven

  • July 13, 2026

Related Content

Escalating anti-tumour necrosis factor exposure with reductions in surgical resection rates in paediatric inflammatory bowel disease: an 18-year real-world population-based cohort study

Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial

The gut-liver-kidney-brain axis in Wilson disease: copper speciation-flux and barrier-mediated organ crosstalk